Luca Puccetti

Carbonic anhydrase inhibitors: Novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX

Vladimír Garaj, Luca Puccetti, G. Fasolis et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 148 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +7

Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff’s bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes

Luca Puccetti, G. Fasolis, Daniela Vullo et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 119 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12

Investigations of the esterase, phosphatase, and sulfatase activities of the cytosolic mammalian carbonic anhydrase isoforms I, II, and XIII with 4-nitrophenyl esters as substrates

Alessio Innocenti, Andrea Scozzafava, Seppo Parkkila et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 118 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +9

Selective Inhibition of Carbonic Anhydrase IX Decreases Cell Proliferation and Induces Ceramide-Mediated Apoptosis in Human Cancer Cells

Fabio Cianchi, Maria Cristina Vinci, Claudiu T. Supuran et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 106 citations

Medicine, Oncology, Pharmacology +14

Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties

Vladimír Garaj, Luca Puccetti, G. Fasolis et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 105 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +9